The current treatment strategy for gouty arthritis
Febuxostat is a non-purine selective inhibitor of isoforms of xanthine oxidoreductase (XOR), the effect of which is aimed at lowering the level of serum uric acid (UA). Febuxostat is a more potent inhibitor of XOR than allopurinol, as confirmed by that target UA levels have been achieved more freque...
में बचाया:
| मुख्य लेखकों: | , , |
|---|---|
| स्वरूप: | लेख |
| भाषा: | रूसी |
| प्रकाशित: |
IMA-PRESS LLC
2018-09-01
|
| श्रृंखला: | Современная ревматология |
| विषय: | |
| ऑनलाइन पहुंच: | https://mrj.ima-press.net/mrj/article/view/844 |
| टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|